ScholarIQanswers from OpenAlex & ORCID
Zofia Piotrowska
ResearcherPublications, citations & collaboration network
Zofia Piotrowska is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Zofia Piotrowska have?
ScholarIQindexed works
Zofia Piotrowska has 352 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Zofia Piotrowska have?
ScholarIQcitation count
Zofia Piotrowska has 10,797 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Zofia Piotrowska?
ScholarIQh-index
Zofia Piotrowska has an h-index of 43 in OpenAlex.
What is the i10-index of Zofia Piotrowska?
ScholarIQi10-index
Zofia Piotrowska has an i10-index of 103 in OpenAlex.
What is the ORCID of Zofia Piotrowska?
ScholarIQorcid
The ORCID for Zofia Piotrowska is on the source record.
What is the OpenAlex record for Zofia Piotrowska?
ScholarIQopenalex
The OpenAlex for Zofia Piotrowska is on the source record.
What are the most-cited papers on Zofia Piotrowska?
ScholarIQmost cited works
<i>EGFR</i> Mutations and <i>ALK</i> Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective Analysis
Justin F. Gainor, Alice T. Shaw, Lecia V. Sequist, Xiujun Fu, Christopher G. Azzoli, Zofia Piotrowska, Tiffany G. Huynh, Ling Zhao, Linnea Fulton, Katherine R. Schultz, Emily Howe, Anna F. Farago, Ryan J. Sullivan, James R. Stone, Subba R. Digumarthy, Teresa Morán, Aaron N. Hata, Yukako Yagi, Beow Y. Yeap, Jeffrey A. Engelman, Mari Mino–Kenudson
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
Aaron N. Hata, Matthew J. Niederst, Hannah L. Archibald, María Gomez‐Caraballo, Faria M. Siddiqui, Hillary E. Mulvey, Yosef E. Maruvka, Fei Ji, Hyo-Eun Carrie Bhang, Viveksagar Krishnamurthy Radhakrishna, Giulia Siravegna, Haichuan Hu, Sana Raoof, Elizabeth L. Lockerman, Anuj Kalsy, Dana Lee, Celina L Keating, David A. Ruddy, Leah J. Damon, Adam Crystal, Carlotta Costa, Zofia Piotrowska, Alberto Bardelli, A. John Iafrate, Ruslan I. Sadreyev, Frank Stegmeier, Gad Getz, Lecia V. Sequist, Anthony C. Faber, Jeffrey A. Engelman
Rociletinib in <i>EGFR</i>-Mutated Non–Small-Cell Lung Cancer
Lecia V. Sequist, Jean‐Charles Soria, Jonathan W. Goldman, Heather A. Wakelee, Shirish M. Gadgeel, Andréa Varga, Vassiliki A. Papadimitrakopoulou, Benjamin Solomon, Geoffrey R. Oxnard, Rafał Dziadziuszko, Dara L. Aisner, Robert C. Doebele, Cathy Galasso, Edward B. Garon, Rebecca S. Heist, Jennifer Logan, Joel W. Neal, Melody Mendenhall, Suzanne Nichols, Zofia Piotrowska, Antoinette J. Wozniak, Mitch Raponi, Chris Karlovich, Sarah Jaw‐Tsai, Jeffrey D. Isaacson, Darrin Despain, Shannon Matheny, Lindsey Rolfe, Andrew R. Allen, D. Ross Camidge
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
Jacob J. Chabon, Andrew D. Simmons, Alexander F. Lovejoy, Mohammad Shahrokh Esfahani, Aaron M. Newman, Henry J. Haringsma, David M. Kurtz, Henning Stehr, Florian Scherer, Chris Karlovich, Thomas C. Harding, Kathleen A. Durkin, Gregory A. Otterson, W. Thomas Purcell, D. Ross Camidge, Jonathan W. Goldman, Lecia V. Sequist, Zofia Piotrowska, Heather A. Wakelee, Joel W. Neal, Ash A. Alizadeh, Maximilian Diehn
The Allelic Context of the C797S Mutation Acquired upon Treatment with Third-Generation EGFR Inhibitors Impacts Sensitivity to Subsequent Treatment Strategies
Matthew J. Niederst, Haichuan Hu, Hillary E. Mulvey, Elizabeth L. Lockerman, Angel R. Garcia, Zofia Piotrowska, Lecia V. Sequist, Jeffrey A. Engelman